NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
NewsRx | Free Newsletters
 
----------
------------
NewsRx on Facebook
-----
NewsRx Passes
Press Release Submissions
PR Login
-----
2008 Award Logo
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
-----
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.

Security by Verisign

Search Results for Adventrx Pharmaceuticals Inc


Filter Articles: Clinical News | Consumer News | Business News | All News | More Options

Results 1 - 20      Next >


Refine Search
Display Mode: Context | Summary
ADVENTRX Announces Acceptance of Compliance Plan by NYSE AMEX
2009 AUG 17 ... fiscal years. Keywords: , Health, Biotechnology, Oncology, Pharmaceutical, Adventrx Pharmaceuticals Inc., Pharmaceutical Business, Pharmaceutical Company,...
Subject: ADVENTRX Pharmaceuticals, Inc.
Price: $3.00
*
ADVENTRX Announces Results From ANX-514 Bioequivalence Study
2009 MAY 18 ... complete pharmacokinetic data were included in the analysis. Keywords: Adventrx Pharmaceuticals Inc., Docetaxel, Drugs, FDA, Pharmaceutical Business, Pharmaceutical Company, ...
Subject: Pharmacokinetics
Price: $3.00
*
ADVENTRX Grants Exclusive Rights to ANX-514 in South Korea
2009 APR 6 ... Mr. Byung Hwa Kim, Chief Executive Officer of Shin Poong. Keywords: Adventrx Pharmaceuticals Inc., Docetaxel, Drug Development, Drugs, Gastric Cancer, Gastric Carcinoma, Infectious ...
Subject: Pharmaceuticals
Price: $3.00
*
ADVENTRX Intends Voluntary Withdrawal From NYSE Amex Upon Approval of NASDAQ Listing
2009 SEP 28 ... with these listing standards. Keywords: Adventrx Pharmaceuticals, Inc., Adventrx Pharmaceuticals Inc., Pharmaceutical Business, Pharmaceutical Company This article was prepared ...
Subject: Adventrx Pharmaceuticals, Inc.
Price: $3.00
*
ADVENTRX Narrows Prior Guidance on NDA Submission Timeline
2009 AUG 17 ... Nanotechnology, Advertising, Emerging Technologies, Marketing, Nanoparticle, Nanotech, Adventrx Pharmaceuticals Inc., Angiology, Biopharmaceuticals, Chemotherapy, Cisplatin, Clinical Trials, Drug ...
Subject: ADVENTRX Pharmaceuticals, Inc.
Price: $3.00
*
ADVENTRX Pharmaceuticals Announces Closing of Financing
2009 JUN 29 ... California 92121 or from the SEC's website at www.sec.gov. Keywords: Adventrx Pharmaceuticals Inc., FDA, Pharmaceutical Business, Pharmaceutical Company, Therapy, Treatment, U.S. Food ...
Subject: Pharmaceuticals
Price: $3.00
*
ADVENTRX Pharmaceuticals Announces Financing
2009 JUN 22 ... California 92121 or from the SEC's website at www.sec.gov. Keywords: Adventrx Pharmaceuticals Inc., FDA, Pharmaceutical Business, Pharmaceutical Company, Therapy, Treatment, U.S. Food ...
Subject: Pharmaceuticals
Price: $3.00
*
ADVENTRX Pharmaceuticals Announces Plans for Remainder of 2009
2009 JUL 13 ... independently toward the NDA submission," Mr. Culley continued. Keywords: Adventrx Pharmaceuticals Inc., FDA, Pharmaceutical Business, Pharmaceutical Company, U.S. Food and Drug ...
Subject: Pharmaceuticals
Price: $3.00
*
ADVENTRX Pharmaceuticals Reports First Quarter 2009 Financial Results
2009 MAY 25 ... 2009, compared to $0.3 million for the same period a year ago. Keywords: Adventrx Pharmaceuticals Inc., Clinical Trial Research, Pharmaceutical Business, Pharmaceutical Company,...
Subject: Pharmaceuticals
Price: $3.00
*
ADVENTRX Pharmaceuticals Reports Second Quarter Financial Results
2009 AUG 24 ... and a $0.1 million decrease in insurance related expenses. Keywords: Adventrx Pharmaceuticals Inc., Biotechnology, Clinical Trial Research, Drug Development, Pharmaceutical Business, ...
Subject: Clinical Trial Research
Price: $3.00
*
ADVENTRX Pharmaceuticals Reports Third Quarter Financial Results
2009 NOV 23 ... and a $0.1 million decrease in insurance related expenses. Keywords: Adventrx Pharmaceuticals Inc., Clinical Trial Research, FDA, Pharmaceutical Business, Pharmaceutical Company, ...
Subject: Clinical Trial Research
Price: $3.00
*
ADVENTRX Pharmaceuticals to Present at the BIO Investor Forum on October 29
2009 NOV 2 ... presentation will be available on the Web site for 30 days. Keywords: Adventrx Pharmaceuticals Inc., Pharmaceutical Business, Pharmaceutical Company,...
Subject: Pharmaceuticals
Price: $3.00
*
ADVENTRX Pharmaceuticals to Present at the BIOCOM Investor Conference on October 26
2009 NOV 1 ... presentation will be available on the Web site for 30 days. Keywords: Adventrx Pharmaceuticals Inc., Pharmaceutical Business, Pharmaceutical Company,...
Subject: Pharmaceuticals
Price: $3.00
*
ADVENTRX Pharmaceuticals, Inc. Reports Fourth Quarter and Full Year 2008 Financial Results
2009 APR 6 ... attributable to lower invested balances and interest rates. Keywords: Adventrx Pharmaceuticals Inc., Pharmaceutical Business, Pharmaceutical Company,...
Subject: Pharmaceuticals
Price: $3.00
*
ADVENTRX Provides Business Update Following Recent Financing Activity
2009 NOV 2 ... Keywords: Adventrx Pharmaceuticals, Inc., U.S. Food and Drug Administration, FDA, Adventrx Pharmaceuticals Inc., Pharmaceutical Business, Pharmaceutical Company This article was prepared ...
Subject: Adventrx Pharmaceuticals, Inc.
Price: $3.00
*
ADVENTRX Provides Update on Strategic Transaction Process
2009 FEB 23 ... in the second quarter." Keywords: Adventrx Pharmaceuticals, Inc., Adventrx Pharmaceuticals Inc., Pharmaceutical Business, Pharmaceutical Company This article was ...
Subject: Adventrx Pharmaceuticals, Inc.
Price: $3.00
*
ADVENTRX Receives Notice From NYSE Amex
2009 JUN 15 ... of the NYSE Amex Company Guide. Keywords: Adventrx Pharmaceuticals, Inc., Adventrx Pharmaceuticals Inc., Pharmaceutical Business, Pharmaceutical Company This article was ...
Subject: Adventrx Pharmaceuticals, Inc.
Price: $3.00
*
Carrie Carlander Joins LifeVantage as Chief Financial Officer
2009 JUN 29 ... Corporation. Prior to Genelux, Ms. Carlander served as Chief Financial Officer for Adventrx Pharmaceuticals. She has also served in the role of Vice President Finance for V-Enable, ... Pharmaceuticals. She has also served in the role of Vice President Finance for V-Enable, Inc. and Websense Inc. Ms. Carlander has an MBA in Finance and Management from San Diego ...
Subject: LifeVantage Corporation
Price: $3.00
*
Transdel Pharmaceuticals Appoints Dr. Joachim P.H. Schupp as Chief Medical Officer
2009 NOV 1 ... and biotechnology companies. He held positions as Vice President of Medical Affairs at Adventrx Pharmaceuticals from 2006 to 2008 and Vice President of Clinical Data Services at ... Transdel Pharmaceuticals, Inc. (BULLETIN BOARD: TDLP) , a specialty pharmaceutical company focused on developing ...
Subject: Pharmaceuticals
Price: $3.00
*

Results 1 - 20      Next >




-----------------------
PR Login